Skip to main content

Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis

Status: Open to Enrollment
Email Us To Enroll

Study Details

View study details on clinicaltrials.gov.

Locations

  • Fremont
  • Palo Alto
  • Berkeley

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

The primary objective of this study is to evaluate the long-term safety of avacopan in participants with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

Robert Su
Robert Su
Principal investigator
View Profile

Co-investigator

Jianling Tao

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?